{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:43:34Z","timestamp":1785908614768,"version":"3.56.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018317","name":"School of Medicine, Virginia Commonwealth University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Radiotherapy is an essential component of breast cancer management; however, interpatient variability in radiation-induced normal tissue toxicity remains a significant clinical challenge. The identification of minimally invasive biomarkers capable of predicting susceptibility to radiotoxicity could facilitate personalized treatment strategies. Extracellular vesicle (EV) microRNAs (miRNAs) are stable in circulation and play key roles in cellular stress and inflammatory responses, making them attractive biomarker candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, plasma-derived EV miRNA profiles were analyzed in breast cancer patients receiving adjuvant radiotherapy and stratified according to the severity and timing of normal tissue toxicity. EVs were isolated using a combined size-exclusion chromatography and precipitation approach and characterized by nanoparticle tracking analysis and protein marker expression. Differential miRNA expression was assessed using quantitative PCR following normalization with stably expressed endogenous controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two EV miRNAs were associated with increased susceptibility to radiotherapy-induced toxicity. MiR-222-3p was significantly upregulated in patients who developed acute high-grade toxicity, while miR-144-5p was increased in both acute and late high-toxicity groups. Additionally, miR-200a-3p and miR-335-3p were enriched in patients exhibiting minimal or no toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings identify EV miRNAs with potential utility as biomarkers of radiation-induced normal tissue toxicity and support further investigation into their mechanistic roles and clinical applicability in personalized radiotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1904861","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:43:34Z","timestamp":1785905014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating extracellular vesicle miRNA as a novel predictive marker of radiation toxicity in breast cancer patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Bridget","family":"Quinn","sequence":"first","affiliation":[{"name":"Massey Comprehensive Cancer Center, Virginia Commonwealth University","place":["Richmond, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"McGinn","sequence":"additional","affiliation":[{"name":"Massey Comprehensive Cancer Center, Virginia Commonwealth University","place":["Richmond, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rabender","sequence":"additional","affiliation":[{"name":"Massey Comprehensive Cancer Center, Virginia Commonwealth University","place":["Richmond, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Arthur","sequence":"additional","affiliation":[{"name":"Massey Comprehensive Cancer Center, Virginia Commonwealth University","place":["Richmond, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Yakovlev","sequence":"additional","affiliation":[{"name":"Massey Comprehensive Cancer Center, Virginia Commonwealth University","place":["Richmond, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.21635","article-title":"Risk factors and preventions of breast cancer","volume":"13","author":"Sun","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-019-00516-9","article-title":"DNA repair in cancer initiation, progression, and therapy-a double-edged sword","volume":"60","author":"Kiwerska","year":"2019","journal-title":"J Appl Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4279724","article-title":"Molecular signatures of radiation response in breast cancer: Towards personalized decision-making in radiation treatment","volume":"2017","author":"Speers","year":"2017","journal-title":"Int J Breast Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1038\/s41598-022-11445-9","article-title":"Association between micrornas 10b\/21\/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide","volume":"12","author":"Stepanovi\u0107","year":"2022","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108583","article-title":"Roles of circulating microrna(s) in human breast cancer","volume":"695","author":"Chong","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122028","article-title":"Exosomes as mirna carriers: Formation-function-future","volume":"17","author":"Yu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194687","article-title":"The role of exo-mirnas in cancer: A focus on therapeutic and diagnostic applications","volume":"20","author":"Ingenito","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155568","article-title":"Non-coding rnas and estrogen receptor signaling in breast cancer: Nanotechnology-based therapeutic approaches","volume":"263","author":"Al Ali","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13118","article-title":"Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (review)","volume":"28","author":"Yang","year":"2023","journal-title":"Mol Med Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12951-018-0403-9","article-title":"Recent advancements in the use of exosomes as drug delivery systems","volume":"16","author":"Bunggulawa","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00467-017-3816-z","article-title":"Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases","volume":"34","author":"St\u00e5hl","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120210","article-title":"Enigmatic role of exosomes in breast cancer progression and therapy","volume":"289","author":"Famta","year":"2022","journal-title":"Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: From biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13514","article-title":"Liquid biopsy in breast cancer: A comprehensive review","volume":"95","author":"Alimirzaie","year":"2019","journal-title":"Clin Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12635","article-title":"Mirnas as radio-response biomarkers for breast cancer stem cells","volume":"14","author":"Gri\u00f1\u00e1n\u2010Lis\u00f3n","year":"2020","journal-title":"Mol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-3105","article-title":"Mir-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ros defense","volume":"78","author":"Pajic","year":"2018","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217443","article-title":"Effect of radiotherapy on the expression of cardiovascular disease-related mirna-146a, -155, -221 and -222 in blood of women with breast cancer","volume":"14","author":"Esplugas","year":"2019","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.70023","article-title":"Hepatocyte-derived extracellular vesicles regulate liver regeneration through a negative feedback mechanism","volume":"3","author":"McGinn","year":"2024","journal-title":"J Extracell Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3791\/56482-v","article-title":"Sample preparation and imaging of exosomes by transmission electron microscopy","volume":"4","author":"Jung","year":"2018","journal-title":"J Vis Exp"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060804","article-title":"Overview and update on extracellular vesicles: Considerations on exosomes and their application in modern medicine","volume":"11","author":"Di Bella","year":"2022","journal-title":"Biol (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145686","article-title":"Isolation of exosomes from blood plasma: Qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods","volume":"10","author":"Baranyai","year":"2015","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep19529","article-title":"Assessing cellular and circulating mirna recovery: The impact of the rna isolation method and the quantity of input material","volume":"6","author":"El-Khoury","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170628","article-title":"A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents","volume":"12","author":"Helwa","year":"2017","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197341","article-title":"Total blood exosomes in breast cancer: Potential role in crucial steps of tumorigenesis","volume":"21","author":"Konoshenko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2021.030705","article-title":"Improved protocol for plasma microrna extraction and comparison of commercial kits","volume":"31","author":"Sriram","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11663","article-title":"Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes","volume":"7","author":"Vardaki","year":"2016","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020156","article-title":"Mir-16-5p is a stably-expressed housekeeping microrna in breast cancer tissues from primary tumors and from metastatic sites","volume":"17","author":"Rinnerthaler","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2015.04.025","article-title":"Housekeeping genes for studies of plasma microrna: A need for more precise standardization","volume":"158","author":"Rice","year":"2015","journal-title":"Surgery"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.08.026","article-title":"Manganese superoxide dismutase in breast cancer: From molecular mechanisms of gene regulation to biological and clinical significance","volume":"77","author":"Becuwe","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m208670200","article-title":"Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in pc-12 cells","volume":"278","author":"Pias","year":"2003","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00411-016-0661-6","article-title":"Human serum mir-34a as an indicator of exposure to ionizing radiation","volume":"55","author":"Halimi","year":"2016","journal-title":"Radiat Environ Biophys"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12236","article-title":"Methodological challenges in utilizing mirnas as circulating biomarkers","volume":"18","author":"Moldovan","year":"2014","journal-title":"J Cell Mol Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1904861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:43:42Z","timestamp":1785905022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1904861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":36,"alternative-id":["10.3389\/fonc.2026.1904861"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1904861","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1904861"}}